New immunomodulating agents and biological response modifiers:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Amsterdam u.a.
Elsevier Biomed. Pr.
1982
|
| Schriftenreihe: | Human cancer immunology
3 |
| Schlagworte: | |
| Beschreibung: | XIII, 164 S. Ill. |
| ISBN: | 0444804013 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV000366039 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 870612s1982 a||| |||| 00||| eng d | ||
| 020 | |a 0444804013 |9 0-444-80401-3 | ||
| 035 | |a (OCoLC)8281348 | ||
| 035 | |a (DE-599)BVBBV000366039 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-188 | ||
| 050 | 0 | |a RC271.I45 | |
| 082 | 0 | |a 616.99/4061 |2 19 | |
| 245 | 1 | 0 | |a New immunomodulating agents and biological response modifiers |c ed. by B. Serrou ... |
| 264 | 1 | |a Amsterdam u.a. |b Elsevier Biomed. Pr. |c 1982 | |
| 300 | |a XIII, 164 S. |b Ill. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Human cancer immunology |v 3 | |
| 650 | 4 | |a Cancer - Chimiothérapie - Congrès | |
| 650 | 4 | |a Immunothérapie - Congrès | |
| 650 | 4 | |a Réaction immunitaire - Régulation - Congrès | |
| 650 | 4 | |a Adjuvants, Immunologic |x therapeutic use |v Congresses | |
| 650 | 4 | |a Antineoplastic Agents |x therapeutic use |v Congresses | |
| 650 | 4 | |a Biological response modifiers | |
| 650 | 4 | |a Cancer |x Chemotherapy |v Congresses | |
| 650 | 4 | |a Immune response |x Regulation |v Congresses | |
| 650 | 4 | |a Immunotherapy |v Congresses | |
| 650 | 4 | |a Neoplasms |x drug therapy |v Congresses | |
| 650 | 4 | |a Neoplasms |x immunology |v Congresses | |
| 650 | 0 | 7 | |a Biological response modifier |0 (DE-588)4475179-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Immunmodulation |0 (DE-588)4315157-7 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1980 |z Brüssel |2 gnd-content | |
| 689 | 0 | 0 | |a Immunmodulation |0 (DE-588)4315157-7 |D s |
| 689 | 0 | 1 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Biological response modifier |0 (DE-588)4475179-5 |D s |
| 689 | 1 | 1 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Serrou, Bernard |e Sonstige |4 oth | |
| 830 | 0 | |a Human cancer immunology |v 3 |w (DE-604)BV000005077 |9 3 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-000227249 | ||
Datensatz im Suchindex
| _version_ | 1804114829913358336 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV000366039 |
| callnumber-first | R - Medicine |
| callnumber-label | RC271 |
| callnumber-raw | RC271.I45 |
| callnumber-search | RC271.I45 |
| callnumber-sort | RC 3271 I45 |
| callnumber-subject | RC - Internal Medicine |
| ctrlnum | (OCoLC)8281348 (DE-599)BVBBV000366039 |
| dewey-full | 616.99/4061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/4061 |
| dewey-search | 616.99/4061 |
| dewey-sort | 3616.99 44061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02069nam a2200553 cb4500</leader><controlfield tag="001">BV000366039</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">870612s1982 a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0444804013</subfield><subfield code="9">0-444-80401-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)8281348</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000366039</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC271.I45</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4061</subfield><subfield code="2">19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New immunomodulating agents and biological response modifiers</subfield><subfield code="c">ed. by B. Serrou ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Amsterdam u.a.</subfield><subfield code="b">Elsevier Biomed. Pr.</subfield><subfield code="c">1982</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIII, 164 S.</subfield><subfield code="b">Ill.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Human cancer immunology</subfield><subfield code="v">3</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer - Chimiothérapie - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunothérapie - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Réaction immunitaire - Régulation - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adjuvants, Immunologic</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biological response modifiers</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Chemotherapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immune response</subfield><subfield code="x">Regulation</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunotherapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">immunology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biological response modifier</subfield><subfield code="0">(DE-588)4475179-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Immunmodulation</subfield><subfield code="0">(DE-588)4315157-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1980</subfield><subfield code="z">Brüssel</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Immunmodulation</subfield><subfield code="0">(DE-588)4315157-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Biological response modifier</subfield><subfield code="0">(DE-588)4475179-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Serrou, Bernard</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Human cancer immunology</subfield><subfield code="v">3</subfield><subfield code="w">(DE-604)BV000005077</subfield><subfield code="9">3</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000227249</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1980 Brüssel gnd-content |
| genre_facet | Konferenzschrift 1980 Brüssel |
| id | DE-604.BV000366039 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T15:12:57Z |
| institution | BVB |
| isbn | 0444804013 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000227249 |
| oclc_num | 8281348 |
| open_access_boolean | |
| owner | DE-12 DE-188 |
| owner_facet | DE-12 DE-188 |
| physical | XIII, 164 S. Ill. |
| publishDate | 1982 |
| publishDateSearch | 1982 |
| publishDateSort | 1982 |
| publisher | Elsevier Biomed. Pr. |
| record_format | marc |
| series | Human cancer immunology |
| series2 | Human cancer immunology |
| spelling | New immunomodulating agents and biological response modifiers ed. by B. Serrou ... Amsterdam u.a. Elsevier Biomed. Pr. 1982 XIII, 164 S. Ill. txt rdacontent n rdamedia nc rdacarrier Human cancer immunology 3 Cancer - Chimiothérapie - Congrès Immunothérapie - Congrès Réaction immunitaire - Régulation - Congrès Adjuvants, Immunologic therapeutic use Congresses Antineoplastic Agents therapeutic use Congresses Biological response modifiers Cancer Chemotherapy Congresses Immune response Regulation Congresses Immunotherapy Congresses Neoplasms drug therapy Congresses Neoplasms immunology Congresses Biological response modifier (DE-588)4475179-5 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Immunmodulation (DE-588)4315157-7 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1980 Brüssel gnd-content Immunmodulation (DE-588)4315157-7 s Krebs Medizin (DE-588)4073781-0 s DE-604 Biological response modifier (DE-588)4475179-5 s Serrou, Bernard Sonstige oth Human cancer immunology 3 (DE-604)BV000005077 3 |
| spellingShingle | New immunomodulating agents and biological response modifiers Human cancer immunology Cancer - Chimiothérapie - Congrès Immunothérapie - Congrès Réaction immunitaire - Régulation - Congrès Adjuvants, Immunologic therapeutic use Congresses Antineoplastic Agents therapeutic use Congresses Biological response modifiers Cancer Chemotherapy Congresses Immune response Regulation Congresses Immunotherapy Congresses Neoplasms drug therapy Congresses Neoplasms immunology Congresses Biological response modifier (DE-588)4475179-5 gnd Krebs Medizin (DE-588)4073781-0 gnd Immunmodulation (DE-588)4315157-7 gnd |
| subject_GND | (DE-588)4475179-5 (DE-588)4073781-0 (DE-588)4315157-7 (DE-588)1071861417 |
| title | New immunomodulating agents and biological response modifiers |
| title_auth | New immunomodulating agents and biological response modifiers |
| title_exact_search | New immunomodulating agents and biological response modifiers |
| title_full | New immunomodulating agents and biological response modifiers ed. by B. Serrou ... |
| title_fullStr | New immunomodulating agents and biological response modifiers ed. by B. Serrou ... |
| title_full_unstemmed | New immunomodulating agents and biological response modifiers ed. by B. Serrou ... |
| title_short | New immunomodulating agents and biological response modifiers |
| title_sort | new immunomodulating agents and biological response modifiers |
| topic | Cancer - Chimiothérapie - Congrès Immunothérapie - Congrès Réaction immunitaire - Régulation - Congrès Adjuvants, Immunologic therapeutic use Congresses Antineoplastic Agents therapeutic use Congresses Biological response modifiers Cancer Chemotherapy Congresses Immune response Regulation Congresses Immunotherapy Congresses Neoplasms drug therapy Congresses Neoplasms immunology Congresses Biological response modifier (DE-588)4475179-5 gnd Krebs Medizin (DE-588)4073781-0 gnd Immunmodulation (DE-588)4315157-7 gnd |
| topic_facet | Cancer - Chimiothérapie - Congrès Immunothérapie - Congrès Réaction immunitaire - Régulation - Congrès Adjuvants, Immunologic therapeutic use Congresses Antineoplastic Agents therapeutic use Congresses Biological response modifiers Cancer Chemotherapy Congresses Immune response Regulation Congresses Immunotherapy Congresses Neoplasms drug therapy Congresses Neoplasms immunology Congresses Biological response modifier Krebs Medizin Immunmodulation Konferenzschrift 1980 Brüssel |
| volume_link | (DE-604)BV000005077 |
| work_keys_str_mv | AT serroubernard newimmunomodulatingagentsandbiologicalresponsemodifiers |